85 results on '"Miranda, Roberto N."'
Search Results
2. Corrigendum to “Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.” [Modern Pathology 34 (2021) 2154–2167]
3. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients
4. Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma
5. Breast Implant-Associated Anaplastic Large Cell Lymphoma
6. Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases
7. Primary Lymphomas of the Breast: A Review
8. Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal–regulated kinase pathway activation
9. Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma
10. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge
11. Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases
12. Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship
13. EZH2 expression is associated with inferior overall survival in mantle cell lymphoma
14. Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease
15. Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse
16. Myeloid/lymphoid neoplasms with FLT3 rearrangement
17. Extranodal NK/T-cell lymphoma, nasal type presenting as primary intestinal lymphoma vs intestinal T-cell lymphoma: A borderline diagnostic category in the revised WHO classification
18. Gamma/Delta Phenotype in Primary Cutaneous T-cell Lymphomas and Lymphoid Proliferations
19. Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
20. Follicular dendritic cell sarcoma in the differential diagnosis of GATA3 positive tumors: A case report
21. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma
22. Programmed Cell Death-One Inhibition Therapy in Classical Hodgkin Lymphoma
23. Breast Implant–Associated Anaplastic Large Cell Lymphoma
24. Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia
25. Chronic myeloid leukemia with insertion-derived BCR–ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis
26. Correction: Chronic myeloid leukemia with insertion-derived BCR–ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis
27. Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update
28. B-cell lymphomas associated with breast implants: Report of three cases and review of the literature
29. Reconsideration of the first recognition of breast implant-associated anaplastic large cell lymphoma: A critical review of the literature
30. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma
31. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma
32. PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma
33. Epstein–Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review
34. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
35. KSHV/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap
36. Unicentric Castleman disease, hyaline vascular variant, stromal rich, with increased plasma cells and a high level of serum IL-6: Raising the diagnostic and therapeutic issues
37. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis
38. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study
39. Breast implant-associated anaplastic large cell lymphoma: a review
40. IL-13 is produced by tumor cells in breast implant–associated anaplastic large cell lymphoma: implications for pathogenesis
41. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
42. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors
43. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course
44. Differential expression of CCR4 in primary cutaneous gamma/delta (γ⁄δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy
45. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma
46. Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature
47. Breast Implant-Associated Anaplastic Large Cell Lymphoma: An Update
48. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 : a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase
49. Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor–α inhibitor therapy and literature review
50. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.